ARCHIVES

FDA Approves Abraxane For Second-Line Treatment Of Metastatic Breast Cancer

This article is from The Cancer Letter archive.

Vol. 28 No. 1 | January 28, 2005

Download PDF Visit The Full Archive

Related Articles

NCAB Delays Approval Of New Comprehensive Center Guidelines

October 12, 1979

Komen, Baylr, UT Southwestern Form Alliance

November 13, 1987

Regulatory Agencies: FDA Regulation Of Tobacco Signed by President Clinton

September 6, 1996

Experts Raise Questions About Influential Swedish Trial Of Mammography Screening.

May 11, 2007

In Brief: Stipends Out For Trainees In new Clinical Program, But They Can Be Paid If Any Money Is Available

May 31, 1974

DCE Board Okays New Melanoma Study, Other Concepts

November 11, 1988